LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 23 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,654,000 | +149.8% | 47,557 | +113.9% | 0.22% | +101.8% |
Q2 2017 | $662,000 | -15.8% | 22,230 | -15.5% | 0.11% | -12.1% |
Q1 2017 | $786,000 | -8.2% | 26,323 | -26.8% | 0.12% | +7.8% |
Q3 2016 | $856,000 | +9.9% | 35,977 | +24.6% | 0.12% | +12.7% |
Q4 2015 | $779,000 | -71.2% | 28,870 | -70.3% | 0.10% | -76.2% |
Q3 2015 | $2,705,000 | +52.4% | 97,350 | +0.4% | 0.43% | +108.8% |
Q1 2015 | $1,775,000 | +0.2% | 97,003 | +1.0% | 0.20% | -17.0% |
Q4 2014 | $1,772,000 | +10.0% | 96,064 | -35.6% | 0.25% | -14.8% |
Q1 2014 | $1,611,000 | – | 149,143 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,872,130 | $77,548,000 | 30.77% |
RTW INVESTMENTS, LP | 1,084,416 | $29,279,000 | 9.67% |
Avoro Capital Advisors LLC | 784,199 | $21,173,000 | 7.29% |
Broadfin Capital, LLC | 1,165,373 | $31,465,000 | 1.94% |
P.A.W. CAPITAL CORP | 50,400 | $1,361,000 | 1.54% |
Belmont Global Advisors, Inc. | 37,522 | $1,013,000 | 1.31% |
Perceptive Advisors | 649,515 | $17,537,000 | 1.30% |
ACUTA CAPITAL PARTNERS, LLC | 82,920 | $2,239,000 | 1.07% |
Iguana Healthcare Management, LLC | 110,000 | $2,970,000 | 0.98% |
Virtus ETF Advisers LLC | 10,250 | $277,000 | 0.76% |